From, Biotech

From Biotech to Fire-Protection: Bio Green Med’s Strategic Pivot

13.02.2026 - 13:42:04 | boerse-global.de

Cyclacel Pharmaceuticals US23254L6039

From Biotech to Fire-Protection: Bio Green Med’s Strategic Pivot - Foto: über boerse-global.de
From Biotech to Fire-Protection: Bio Green Med’s Strategic Pivot - Foto: über boerse-global.de

Bio Green Med Solution, Inc., the post-restructuring entity formerly known as Cyclacel Pharmaceuticals, has entered a measured, quiet phase as it executes a newly defined industrial strategy. By the end of 2025, the group had shed its identity as a pure biotech developer, and market observers are now watching how its revamped plan unfolds. The central question remains whether the bold shift into fire-protection solutions will deliver the financial stability investors seek.

Significant operational changes were formalized in September 2025. The company now trades under the name Bio Green Med Solution, Inc. and has completed the acquisition of the Malaysian firm Fitters Sdn. Bhd. This move marks a definitive departure from its original Read more...

So schätzen die Börsenprofis From Aktien ein!

<b>So schätzen die Börsenprofis From Aktien ein!</b>
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen – dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
FĂĽr. Immer. Kostenlos.
US23254L6039 | FROM | boerse | 68578392 |